fosphenytoin
chemical compound
≈ 1 min read
Names in other languages
- cyffosffenytoin
- Englishfosphenytoin
- RomânăFosfenitoină
- Češtinafosfenytoin
- nnfosfenytoin
- shFosfenitoin
- Српскифосфенитол
- 日本語フォスフェニトイン
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Fosphenytoin, also known as fosphenytoin sodium, and sold under the brand name Cerebyx among others, is a water-soluble phenytoin prodrug that is administered intravenously to deliver phenytoin, potentially more safely than intravenous phenytoin. It is used in the acute treatment of convulsive status epilepticus. Fosphenytoin was developed in 1996.
History
Phenytoin, in both its acidic and sodium salt forms, is erratically bioavailable whether it is injected or taken orally due to its high melting point, weak acidity, and its being only sparingly soluble in water. Simply putting patients on other drugs is not always an option; this was especially true before 1993, when the number of anticonvulsants available was much more limited.
One solution was to develop a prodrug that did not have these drawbacks. Fosphenytoin was approved by the US Food and Drug Administration (FDA) in August 1996, for use in epilepsy.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329255061 under CC BY-SA 4.0; modifications have been made.